A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
4-Hydroxytestosterone
Nisoxetine
The risk or severity of adverse effects can be increased when Nisoxetine is combined with Lemborexant.
4-Hydroxytestosterone
Viloxazine
The risk or severity of adverse effects can be increased when Viloxazine is combined with Lemborexant.
4-Hydroxytestosterone
Edivoxetine
The risk or severity of adverse effects can be increased when Edivoxetine is combined with Lemborexant.
4-Hydroxytestosterone
Lofentanil
The risk or severity of adverse effects can be increased when Lofentanil is combined with Lemborexant.
4-Hydroxytestosterone
Etizolam
The risk or severity of adverse effects can be increased when Etizolam is combined with Lemborexant.
4-Hydroxytestosterone
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Lemborexant.
4-Hydroxytestosterone
Stiripentol
The risk or severity of adverse effects can be increased when Stiripentol is combined with Lemborexant.
4-Hydroxytestosterone
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Lemborexant.
4-Hydroxytestosterone
Benzoctamine
The risk or severity of adverse effects can be increased when Benzoctamine is combined with Lemborexant.
4-Hydroxytestosterone
Brotizolam
The risk or severity of adverse effects can be increased when Brotizolam is combined with Lemborexant.
4-Hydroxytestosterone
Butriptyline
The risk or severity of adverse effects can be increased when Butriptyline is combined with Lemborexant.
4-Hydroxytestosterone
Captodiame
The risk or severity of adverse effects can be increased when Captodiame is combined with Lemborexant.
4-Hydroxytestosterone
Beclamide
The risk or severity of adverse effects can be increased when Beclamide is combined with Lemborexant.
4-Hydroxytestosterone
Cyamemazine
The risk or severity of adverse effects can be increased when Cyamemazine is combined with Lemborexant.
4-Hydroxytestosterone
Dimetacrine
The risk or severity of adverse effects can be increased when Dimetacrine is combined with Lemborexant.
4-Hydroxytestosterone
Eperisone
The risk or severity of adverse effects can be increased when Eperisone is combined with Lemborexant.
4-Hydroxytestosterone
Etifoxine
The risk or severity of adverse effects can be increased when Etifoxine is combined with Lemborexant.
4-Hydroxytestosterone
Hexamethonium
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lemborexant.
4-Hydroxytestosterone
Ifenprodil
The risk or severity of adverse effects can be increased when Ifenprodil is combined with Lemborexant.
4-Hydroxytestosterone
Amperozide
The risk or severity of adverse effects can be increased when Amperozide is combined with Lemborexant.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3